GRM5 and Alzheimer disease: mGluR5 dysregulation in the aged brain is now also emerging as a key mediator of Alzheimer’s disease (AD) pathology, in which synaptic maintenance is strongly impaired (Lee et al., 1995, 2004; Li et al., 2009).